Cargando…

ICSBP-induced PD-L1 enhances osteosarcoma cell growth

BACKGROUND: Interferon (IFN) consensus sequence binding protein (ICSBP) is a transcription factor induced by IFN-γ. We previously reported that ICSBP expression promotes osteosarcoma progression by enhancing transforming growth factor-β signaling. In cancer cells, programmed death-ligand 1 (PD-L1) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Jee Young, Kim, June Hyuk, Kang, Hyun Guy, Park, Jong Woong, Park, Seog-Yun, Park, Byung-Kiu, Kim, Yong-Nyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555079/ https://www.ncbi.nlm.nih.gov/pubmed/36249036 http://dx.doi.org/10.3389/fonc.2022.918216

Ejemplares similares

Osteosarcoma in Adolescents and Young Adults
por: Lee, Jun Ah, et al.
Publicado: (2021)

Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults
por: Ju, Hee Young, et al.
Publicado: (2022)

Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells
por: Sung, J Y, et al.
Publicado: (2014)

New 3-dimensional implant application as an alternative to allograft in limb salvage surgery: a technical note on 10 cases
por: Park, Jong Woong, et al.
Publicado: (2020)

Favorable outcome of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with nonmetastatic osteosarcoma and low-degree necrosis
por: Hong, Kyung Taek, et al.
Publicado: (2022)

Huge Intrathoracic Malignant Peripheral Nerve Sheath Tumor in an Adolescent with Neurofibromatosis Type 1
por: Yoon, Jong Hyung, et al.
Publicado: (2014)

Evaluation of Intraosseous Pressure during Pelvic Percutaneous Cement Injection: An In Vitro Study in Swine
por: Lee, Yu Na, et al.
Publicado: (2022)

Percutaneous Cementoplasty for the Pelvis in Bone Metastasis: 12-Year Experience
por: Park, Jong Woong, et al.
Publicado: (2021)

New established cell lines from undifferentiated pleomorphic sarcoma for in vivo study
por: Lee, Eun-Young, et al.
Publicado: (2023)

Joint-preserving palliative surgery using self-locking screws of intramedullary nail and percutaneous cementoplasty for proximal humeral metastasis in the advanced cancer patients
por: Park, Jong Woong, et al.
Publicado: (2018)

Fabrication of a lattice structure with periodic open pores through three-dimensional printing for bone ingrowth
por: Park, Jong Woong, et al.
Publicado: (2022)

Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor
por: Kim, Hyeryeong, et al.
Publicado: (2017)

AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency
por: Schwieger, Maike, et al.
Publicado: (2002)

Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes
por: Lee, Suk Jun, et al.
Publicado: (2023)

Whole Blood Titanium Concentration after Limb Salvage Surgery with Three-Dimensional-Printed Ti6Al4V Implants
por: Park, Jong Woong, et al.
Publicado: (2023)

ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α(+) Dendritic Cells
por: Schiavoni, Giovanna, et al.
Publicado: (2002)

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
por: Song, Joon Seon, et al.
Publicado: (2019)

Long-term treatment outcome of Castleman’s disease: A real-world experience
por: Min, Gi-June, et al.
Publicado: (2022)

Dynamic alterations in PD-1/PD-L1 expression level and immune cell profiles based on radiation response status in mouse tumor model
por: Yoon, Yi Na, et al.
Publicado: (2022)

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition
por: Claaß, Luise Victoria, et al.
Publicado: (2022)

Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model
por: Moon, Chung-Man, et al.
Publicado: (2023)

VEGFR2 Promotes Metastasis and PD-L2 Expression of Human Osteosarcoma Cells by Activating the STAT3 and RhoA-ROCK-LIMK2 Pathways
por: Zheng, Bingxin, et al.
Publicado: (2020)

Development of a Margin Determination Framework for Tumor-Tracking Radiation Therapy With Intraoperatively Implanted Fiducial Markers
por: Kim, Jihun, et al.
Publicado: (2021)

A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia–like syndrome in BXH-2 mice
por: Turcotte, Karine, et al.
Publicado: (2005)

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
por: Bae, Soong June, et al.
Publicado: (2021)

Long-Term Clinical Outcomes in Treatment-Naïve Patients With Orbital Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Single-Center Study
por: Min, Gi-June, et al.
Publicado: (2022)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML
por: Min, Gi-June, et al.
Publicado: (2023)

Novel Immunotherapies for Osteosarcoma
por: Lu, Yubao, et al.
Publicado: (2022)

Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer
por: Yim, Hyun Ee, et al.
Publicado: (2021)

Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
por: Chardin, Laure, et al.
Publicado: (2021)

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer
por: Cheng, Chao, et al.
Publicado: (2022)

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity
por: Lee, Wongeun, et al.
Publicado: (2022)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
por: Lee, Boram, et al.
Publicado: (2021)

Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines
por: Park, Ji-Eun, et al.
Publicado: (2020)

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma
por: Shi, Binhao, et al.
Publicado: (2023)

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
por: Koirala, Pratistha, et al.
Publicado: (2016)

Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway
por: Scheffel, Thamiris Becker, et al.
Publicado: (2021)

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
por: Tian, Tian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3mf9g4lbs4d2dcda07k762voha